Strategic Partnerships Recent SteriTech partnership signals demand for advanced pharma equipment in Europe and the UK/Ireland region. This presents a clear opportunity to expand the partner network, co-market bundled offerings, and lock in channel-driven opportunities. Propose joint go-to-market plays with SteriTech and additional distributors to accelerate deals in sterile processing, cleaning, and isolation solutions.

ATMP Growth BioAir ATMP Solutions integration broadens IWT Pharma's portfolio to cell and gene therapy manufacturing. Target ATMP and gene therapy facilities needing scalable containment and sterility assurance. Position as a one-stop vendor for cGMP cleaning, advanced isolation, and ATMP production support, and pursue pilot projects to validate value.

Automation Advantage IWT Pharma's modern Italian production hub features laser cutting, robotics, automated warehousing, and 3D design for tailored solutions. Leverage these capabilities to cross-sell automated cleaning systems, CIP/COP technologies, and isolation modules that improve sterility, throughput, and compliance. Propose turnkey or co-engineering projects for new lines.

European Footprint Strategic location near Milan enables local manufacturing and rapid service for European customers. Emphasize proximity for on-site support, spare parts, and faster validation cycles, which reduces downtime and accelerates time to market for regulated products.

Expertise & Compliance With decades of experience across pharma, biotech, ATMP, nutraceuticals, and cosmetics, IWT Pharma positions itself as a trusted supplier of end-to-end sterile processing solutions. Highlight proven capabilities in cleaning, isolation, and sterility assurance to differentiate from competitors and pursue higher-value contracts with risk-focused customers.